Dali Pharmaceuticalco.,Ltd
SSE:603963.SS
1.18 (CNY) • At close February 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 14.194 | 43.839 | 180.659 | 63.333 | 82.633 | 101.698 | 69.754 | 68.475 | 66.028 | 28.548 | 76.867 | 80.485 |
| Short Term Investments
| 206.738 | 229.233 | 132.444 | 240.748 | 225.23 | 225.188 | 234.3 | 13.17 | 51.704 | 71.581 | 10 | 19 |
| Cash and Short Term Investments
| 220.932 | 273.072 | 313.102 | 304.08 | 307.863 | 326.886 | 304.054 | 81.645 | 117.731 | 100.129 | 86.867 | 99.485 |
| Net Receivables
| 1.866 | 7.727 | 9.983 | 10.368 | 17.384 | 35.088 | 16.477 | 0.14 | 0.221 | 11.292 | 8.005 | 7.491 |
| Inventory
| 63.842 | 27.021 | 25.42 | 69.912 | 58.885 | 67.619 | 116.021 | 55.009 | 63.037 | 64.747 | 60.991 | 23.764 |
| Other Current Assets
| 2.47 | 0.912 | 0.04 | 4.098 | 5.995 | 0.685 | 0.789 | 1.661 | 1.494 | 1.928 | 8.894 | 6.574 |
| Total Current Assets
| 289.148 | 308.732 | 348.545 | 388.459 | 390.127 | 430.106 | 437.34 | 138.455 | 182.483 | 176.351 | 164.756 | 129.823 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 82.959 | 86.584 | 138.779 | 127.423 | 106.247 | 95.192 | 109.396 | 122.168 | 137.873 | 150.939 | 155.399 | 132.627 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 34.953 | 35.95 | 54.002 | 55.7 | 57.166 | 58.525 | 60.01 | 27.647 | 28.423 | 29.108 | 30.176 | 34.13 |
| Goodwill and Intangible Assets
| 34.953 | 35.95 | 54.002 | 55.7 | 57.166 | 58.525 | 60.01 | 27.647 | 28.423 | 29.108 | 30.176 | 34.13 |
| Long Term Investments
| 0.063 | 63.668 | 192.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.769 | 162.977 |
| Tax Assets
| 4.866 | 6.984 | 7.42 | 7.104 | 7.571 | 10.137 | 4.994 | 1.689 | 1.602 | 1.036 | 1.289 | 2.001 |
| Other Non-Current Assets
| 61.845 | 1.568 | -192.781 | 0.025 | 0.217 | 0.551 | 1.022 | 1.494 | 1.187 | 1.242 | 1.769 | -162.977 |
| Total Non-Current Assets
| 184.686 | 194.754 | 200.201 | 190.252 | 171.201 | 164.405 | 175.422 | 152.997 | 169.084 | 182.325 | 186.864 | 168.758 |
| Total Assets
| 473.834 | 503.486 | 548.746 | 578.711 | 561.329 | 594.51 | 612.763 | 291.453 | 351.567 | 358.676 | 351.62 | 298.58 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 10.191 | 9.1 | 24.535 | 28.694 | 13.745 | 9.208 | 28.294 | 13.445 | 14.533 | 8.374 | 43.395 | 4.088 |
| Short Term Debt
| 8.01 | 0 | 0 | 0 | 0 | 0 | 50 | 20 | 50 | 50 | 0 | 0 |
| Tax Payables
| 2.96 | 5.618 | 3.916 | 1.646 | 3.539 | 6.352 | 3.893 | 6.511 | 4.336 | 8.786 | -21.655 | -13.021 |
| Deferred Revenue
| 19.436 | 4.429 | 48.597 | 57.944 | 5.361 | 10.548 | 61.99 | 38.799 | 35.84 | 19.282 | -16.189 | 71.303 |
| Other Current Liabilities
| 36.371 | 58.633 | 57.437 | 3.831 | 75.688 | 114.096 | 66.56 | 39.496 | 41.133 | 20.762 | 72.397 | 117.061 |
| Total Current Liabilities
| 76.968 | 77.779 | 90.878 | 92.114 | 92.973 | 129.656 | 148.747 | 79.452 | 110.002 | 87.922 | 94.136 | 108.128 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 14.849 | 23.781 | 38.422 | 15.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25 |
| Deferred Revenue Non-Current
| 0.347 | 0.435 | 0.523 | 0.611 | 0.699 | 0.699 | 0.589 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.545 | 0.335 | 0.067 | 0.112 | 0.034 | 0.028 | 0 | 0.026 | 0.256 | 0.237 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 15.741 | 24.551 | 39.011 | 15.742 | 0.733 | 0.727 | 0.589 | 0.026 | 0.256 | 0.237 | 0 | 25 |
| Total Liabilities
| 92.709 | 102.33 | 129.888 | 107.857 | 93.706 | 130.383 | 149.336 | 79.478 | 110.258 | 88.159 | 94.136 | 133.128 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 219.7 | 219.7 | 219.7 | 219.7 | 169 | 130 | 100 | 75 | 75 | 50 | 50 | 50 |
| Retained Earnings
| 10.957 | 30.988 | 48.69 | 100.687 | 97.931 | 95.862 | 96.262 | 111.89 | 147.576 | 192.102 | 179.069 | 87.037 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 32.669 | 32.669 | 32.669 | 32.193 | 30.766 | 29.666 | 25.086 | 18.734 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 150.468 | 117.799 | 117.799 | 117.799 | 168.499 | 207.499 | 237.499 | 0 | 0 | 28.415 | 2.204 | 28.415 |
| Total Shareholders Equity
| 381.125 | 401.156 | 418.858 | 470.855 | 467.623 | 464.128 | 463.427 | 211.975 | 241.31 | 270.517 | 257.484 | 165.452 |
| Total Equity
| 381.125 | 401.156 | 418.858 | 470.855 | 467.623 | 464.128 | 463.427 | 211.975 | 241.31 | 270.517 | 257.484 | 165.452 |
| Total Liabilities & Shareholders Equity
| 473.834 | 503.486 | 548.746 | 578.711 | 561.329 | 594.51 | 612.763 | 291.453 | 351.567 | 358.676 | 351.62 | 298.58 |